HESKA CORP.
HESKA CORP.
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: HSKA
ISIN:

Heska Corporation to Present at Upcoming Piper Jaffray Healthcare Conference

  • 44
Heska Corporation to Present at Upcoming Piper Jaffray Healthcare Conference

PR Newswire

LOVELAND, Colo., Nov. 14, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present during at the 2019 Piper Jaffray Annual Healthcare Conference on Thursday, December 5, 2019 at 11:30 a.m. ET at the Lotte New York Palace in New York, NY.

Heska Corporation (PRNewsfoto/Heska Corporation)

In addition to the presentation, Mr. Wilson and Heska's Chief Financial Officer, Catherine Grassman, will be available for one-on-one meetings on December 5th.  To schedule a meeting, please contact Piper Jaffray via [email protected] or Heska Investor Relations at [email protected].

A live webcast of the company's presentation can be accessed at https://ir.heska.com/. The webcast will be archived after the event, and a replay will be available on the company's website for 90 days. 

For more information about the Piper Jaffray Annual Healthcare Conference, visit: http://www.piperjaffray.com/2col.aspx?id=365.

About Heska
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through two business segments. The Core Companion Animal Health ("CCA") segment represents approximately 85% of revenues, and the Other Vaccines and Pharmaceuticals ("OVP") segment represents approximately 15% of revenues, as of September 30, 2019. CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-corporation-to-present-at-upcoming-piper-jaffray-healthcare-conference-300958200.html

SOURCE Heska Corporation

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.